{
    "clinical_study": {
        "@rank": "94052", 
        "arm_group": [
            {
                "arm_group_label": "rLP2086 lot 1", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "rLP2086 lot 2", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "rLP2086 lot 3", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Active Comparator", 
                "description": "Havrix (HAV) and Saline"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is looking at a new vaccine that might prevent meningococcal disease, and will\n      study whether healthy adolescent subjects receiving different lots of vaccine respond in a\n      similar way. The study will also look at the safety of the new vaccine as well as how it is\n      tolerated."
        }, 
        "brief_title": "A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged \u226510 to <19 Years", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Meningococcal Vaccine", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male or female subject aged >=10 and <19 years at the time of enrollment.\n\n          2. Healthy subject as determined by medical history, physical examination, and judgment\n             of the investigator.\n\n          3. Negative urine pregnancy test for all female subjects.\n\n        Exclusion Criteria:\n\n          1. Previous vaccination with any meningococcal serogroup B vaccine.\n\n          2. Subjects who have received prior HAV vaccination.\n\n          3. Subjects who are scheduled to receive 1 or more doses of an HPV vaccine as part of a\n             3-dose series during the period between Visit 1 and 28 days after the second\n             vaccination.\n\n          4. Subjects receiving any allergen immunotherapy with a nonlicensed product or receiving\n             allergen immunotherapy with a licensed product and are not on stable maintenance\n             doses.\n\n          5. A known or suspected defect of the immune system that would prevent an immune\n             response to the vaccine, such as subjects with congenital or acquired defects in B\n             cell function, those receiving chronic systemic (oral, intravenous, or intramuscular)\n             corticosteroid therapy, or those receiving immunosuppressive therapy.  Subjects in\n             the United States with terminal complement deficiency are excluded from participation\n             in this study.\n\n          6. Significant neurological disorder or history of seizure (excluding simple febrile\n             seizure).\n\n          7. Current chronic use of systemic antibiotics.\n\n          8. Received any investigational vaccines, drugs, or devices within 28 days before\n             administration of the first study vaccination.\n\n          9. Any neuroinflammatory or autoimmune condition, including, but not limited to,\n             transverse myelitis, uveitis, optic neuritis, and multiple sclerosis."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "18 Years", 
            "minimum_age": "10 Years"
        }, 
        "enrollment": {
            "#text": "3600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01830855", 
            "org_study_id": "B1971009", 
            "secondary_id": "6108A1-3001"
        }, 
        "intervention": [
            {
                "arm_group_label": "rLP2086 lot 1", 
                "description": "0.5 mL dose, given at 0, 2 and 6 months (lot 1)", 
                "intervention_name": "rLP2086", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "rLP2086 lot 2", 
                "description": "0.5 mL dose, given at 0, 2 and 6 months (lot 2)", 
                "intervention_name": "rLP2086", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "rLP2086 lot 3", 
                "description": "0.5 mL dose, given at 0, 2 and 6 months (lot 3)", 
                "intervention_name": "rLP2086", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "Control", 
                "description": "0.5 mL dose or 1.0 mL dose dependent on age given at month 0 and 6.", 
                "intervention_name": "Havrix (HAV)", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "Control", 
                "description": "0.5 mL dose of sterile normal saline for injection.", 
                "intervention_name": "Saline", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 14, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1971009&StudyName=A%20trial%20to%20assess%20the%20lot%20consistency%2C%20safety%2C%20tolerability%20and%20immunogenicity%20of%20bivalent%20rLP2086%20vaccine%20when%20given%20to%20healthy%20sub"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35205"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35235"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dothan", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "36305"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tempe", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85282"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Harrisburg", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72432"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jonesboro", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72401"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72205"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92103-6204"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Colorado Springs", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80922"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hialeah", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33012"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32216"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Melbourne", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32935"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dalton", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30721"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "DeKalb", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60115"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46256"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mishawaka", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46545"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Albany", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "47150"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Augusta", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67010"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newton", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67114"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67212-1315"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67207"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67205"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bardstown", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40004"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40291"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mountain Sterling", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40353"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "MT. Sterling", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40353"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Owensboro", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "42301"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eunice", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70535"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Haughton", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "71037"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Metairie", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70006"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rockville", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20850"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Niles", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "49120"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stevensville", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "49127"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Paul", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55108"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Flowood", 
                        "country": "United States", 
                        "state": "Mississippi", 
                        "zip": "39232"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63141"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bellevue", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68005"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Omaha", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68134"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Omaha", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68131"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mineola", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11501"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14609"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Asheboro", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27203"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cary", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27518"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27614"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27609"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44121"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dayton", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45414"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dayton", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45406"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Erie", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "16508"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15226"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Uniontown", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15401"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Upper St. Clair", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15241"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hendersonville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37075"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kingsport", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37660"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lebanon", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37087"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlottesville", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "22902"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vienna", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "22180"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98664"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sudbury", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "P3E 1H5"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G 1N8"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H4N 3C5"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sherbrooke", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "J1H 1Z1"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quebec", 
                        "country": "Canada", 
                        "zip": "G1W 4R4"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quebec", 
                        "country": "Canada", 
                        "zip": "G3K 2P8"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brandys nad Labem - Stara Boleslav", 
                        "country": "Czech Republic", 
                        "zip": "25001"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hradec Kralove", 
                        "country": "Czech Republic", 
                        "zip": "500 05"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hradec Kralove", 
                        "country": "Czech Republic", 
                        "zip": "50002"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jindrichuv Hradec", 
                        "country": "Czech Republic", 
                        "zip": "37701"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Odolena Voda", 
                        "country": "Czech Republic", 
                        "zip": "25070"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pardubice", 
                        "country": "Czech Republic", 
                        "zip": "53002"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pardubice", 
                        "country": "Czech Republic", 
                        "zip": "53012"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Praha 6", 
                        "country": "Czech Republic", 
                        "zip": "16000"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Helsinki", 
                        "country": "Finland", 
                        "zip": "00930"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "J\u00e4rvenp\u00e4\u00e4", 
                        "country": "Finland", 
                        "zip": "04400"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oulu", 
                        "country": "Finland", 
                        "zip": "90220"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vantaa", 
                        "country": "Finland", 
                        "zip": "01300"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuerzburg", 
                        "country": "Germany", 
                        "state": "Bavaria", 
                        "zip": "97070"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bramsche", 
                        "country": "Germany", 
                        "state": "Niedersachsen", 
                        "zip": "49565"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kehl", 
                        "country": "Germany", 
                        "zip": "77684"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Genova", 
                        "country": "Italy", 
                        "zip": "16132"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "zip": "20122"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ragusa", 
                        "country": "Italy", 
                        "zip": "97100"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sassari", 
                        "country": "Italy", 
                        "zip": "07100"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Debica", 
                        "country": "Poland", 
                        "zip": "39-200"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kielczow", 
                        "country": "Poland", 
                        "zip": "55-093"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Krakow", 
                        "country": "Poland", 
                        "zip": "31-202"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lublin", 
                        "country": "Poland", 
                        "zip": "20-044"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Siemianowice Slaskie", 
                        "country": "Poland", 
                        "zip": "41-103"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wroclaw", 
                        "country": "Poland", 
                        "zip": "50-452"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Southampton", 
                        "country": "United Kingdom", 
                        "state": "Hampshire", 
                        "zip": "SO16 6YD"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bristol", 
                        "country": "United Kingdom", 
                        "zip": "BS2 8DX"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SW17 0RE"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oxford", 
                        "country": "United Kingdom", 
                        "zip": "OX3 7LE"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada", 
                "Czech Republic", 
                "Finland", 
                "Germany", 
                "Italy", 
                "Poland", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "4", 
        "official_title": "A Phase 3, Randomized, Active-controlled, Observer-blinded Trial to Assess the Lot Consistency, Safety, Tolerability, and Immunogenicity of a Meningococcal Serogroup B Bivalent rLP2086 Vaccine in Healthy Subjects Aged \u226510 to <19 Years", 
        "overall_contact": {
            "last_name": "Pfizer CT.gov Call Center", 
            "phone": "1-800-718-1021"
        }, 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Proportion of subjects with  titer \u2265 lower limit of quantitation (LLOQ) for all of the 4 primary test strains combined, at 1 month after the third vaccination with bivalent rLP2086 vaccine.", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "measure": "Proportion of subjects achieving at least a 4-fold increase in titer from baseline to 1 month after the third vaccination with bivalent rLP2086 vaccine for each of the 4 primary test strains.", 
                "safety_issue": "No", 
                "time_frame": "Baseline, month 7"
            }, 
            {
                "measure": "Geometric mean titers 1 month after the third vaccination with bivalent rLP2086 for each of the 2 primary test strains.", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "measure": "Percentage of subjects reporting local reactions,  systemic events and antipyretic use for 7 days after each vaccination visit.", 
                "safety_issue": "Yes", 
                "time_frame": "Month 0"
            }, 
            {
                "measure": "Percentage of subjects reporting local reactions,  systemic events and antipyretic use for 7 days after each vaccination visit.", 
                "safety_issue": "Yes", 
                "time_frame": "Month 2"
            }, 
            {
                "measure": "Percentage of subjects reporting local reactions,  systemic events and antipyretic use for 7 days after each vaccination visit.", 
                "safety_issue": "Yes", 
                "time_frame": "Month 6"
            }, 
            {
                "measure": "Percentage of subjects with at least 1 SAE 30 days after any vaccination, during the vaccination phase, during the follow-up phase, and throughout the study period.", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 12 months"
            }, 
            {
                "measure": "Percentage of subjects with at least 1 medically attended adverse event 30 days after each vaccination, 30 days after any vaccination, during the vaccination phase, during the follow-up phase, and throughout the study period.", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 12 months"
            }, 
            {
                "measure": "Percentage of subjects with at least 1 newly diagnosed chronic medical condition 30 days after each vaccination, 30 days after any vaccination, during the vaccination phase, during the follow-up phase, and throughout the study period.", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 12 months"
            }, 
            {
                "measure": "Percentage of subjects with at least 1 adverse event 30 days after each vaccination, 30 days after any vaccination and during the vaccination phase.", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 7 months"
            }, 
            {
                "measure": "Percentage of subjects reporting at least 1 immediate AE after each vaccination.", 
                "safety_issue": "Yes", 
                "time_frame": "Month 0"
            }, 
            {
                "measure": "Percentage of subjects reporting at least 1 immediate AE after each vaccination.", 
                "safety_issue": "Yes", 
                "time_frame": "Month 2"
            }, 
            {
                "measure": "Percentage of subjects reporting at least 1 immediate AE after each vaccination.", 
                "safety_issue": "Yes", 
                "time_frame": "Month 6"
            }, 
            {
                "measure": "Subject's days missing school or work due to AEs during the vaccination phase.", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 7 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01830855"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Proportion of subjects with a titer \u2265 lower limit of quantitation (LLOQ) for each of 10 test strains 1 month after the third vaccination.", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "measure": "Proportion of subjects with a titer \u2265 lower limit of quantitation (LLOQ) for each of 10 test strains 1 month after the second vaccination.", 
                "safety_issue": "No", 
                "time_frame": "Month 3"
            }, 
            {
                "measure": "Proportion of  subjects with a titer \u2265 lower limit of quantitation (LLOQ) for each of the 4 primary test strains at baseline with bivalent rLP2086 vaccine.", 
                "safety_issue": "No", 
                "time_frame": "Month 0"
            }, 
            {
                "measure": "Proportion of  subjects with a titer \u2265 lower limit of quantitation (LLOQ) for each of the 4 primary test strains 1 month after the second vaccination with bivalent rLP2086 vaccine.", 
                "safety_issue": "No", 
                "time_frame": "Month 3"
            }, 
            {
                "measure": "Proportion of subjects achieving at least a 4-fold increase in titer from baseline to 1 month after the second vaccination with bivalent rLP2086 vaccine for each of the primary test strains sets.", 
                "safety_issue": "No", 
                "time_frame": "Baseline, month 3"
            }, 
            {
                "measure": "Proportion of subjects achieving at least a 4-fold increase in titer from baseline to 1 month after the third vaccination with bivalent rLP2086 vaccine for each of the primary test strains sets.", 
                "safety_issue": "No", 
                "time_frame": "Baseline, month 7"
            }, 
            {
                "measure": "Geometric mean titers at baseline with bivalent rLP2086 for each of the primary test strain sets.", 
                "safety_issue": "No", 
                "time_frame": "Month 0"
            }, 
            {
                "measure": "Geometric mean titers 1 month after the second vaccination with bivalent rLP2086 for each of the primary test strain sets.", 
                "safety_issue": "No", 
                "time_frame": "Month 3"
            }, 
            {
                "measure": "Proportions of subjects achieving hSBA titers of \u2265LLOQ, \u22651:4, \u22651:8, \u22651:16, \u22651:32, \u22651:64, and \u22651:128 1 month after the second vaccination with bivalent rLP2086 vaccine for each of the", 
                "safety_issue": "No", 
                "time_frame": "Month 3"
            }, 
            {
                "measure": "primary test strains sets.", 
                "safety_issue": "No", 
                "time_frame": "Month 3"
            }, 
            {
                "measure": "Proportions of subjects achieving hSBA titers of \u2265LLOQ, \u22651:4, \u22651:8, \u22651:16, \u22651:32, \u22651:64, and \u22651:128 1 month after the third vaccination with bivalent rLP2086 vaccine for each of the", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "measure": "primary test strains sets.", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "measure": "Proportion of subjects achieving at least a 3-fold increase in titer from baseline to 1 month after the third vaccination with bivalent rLP2086 vaccine for each of the primary test strains sets.", 
                "safety_issue": "No", 
                "time_frame": "Baseline, month 7"
            }, 
            {
                "measure": "Proportion of subjects achieving at least a 2-fold increase in titer from baseline to 1 month after the third vaccination with bivalent rLP2086 vaccine for each of the primary test strains sets.", 
                "safety_issue": "No", 
                "time_frame": "Baseline, month 7"
            }
        ], 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}